In this context, STIM1/Orai1/TRPC proteins may represent valuable therapeutic targets for testing compounds/drugs that regulate Ca2+ signal alteration in DMD, and focused studies in this field are highly desirable. The gene discussed is STIM1; the disease is Duchenne muscular dystrophy.